| 上海 | トルコ | オーストリア | |
| 放射線治療 | から $6,500 | から $3,500 | から $6,700 |
| 腎がん放射線治療 | ≈ $9,000 | から $5,000 | から $6,700 |
| 脳腫瘍に対する放射線療法 | から $9,000 | から $4,000 | から $6,700 |
| 胃がんの放射線治療 | ≈ $9,000 | から $4,000 | から $6,700 |
| 肺癌放射線療法 | から $7,500 | から $5,000 | から $6,700 |
Bookimedは放射線治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。到着時にクリニックで放射線治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。放射線治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。放射線治療の旅路でお一人になることはありません。
Li Guiyuan, MD, is Chief Physician in the Department of Medical Oncology at Shanghai Tongji Hospital. He has practiced oncology since 1996 and has more than 20 years of experience. He earned a master’s degree in Oncology from Nanjing University in 2003. He has worked in the hospital’s Oncology Department since then.
His clinical work includes chemotherapy for lung, breast, ovarian, and gastrointestinal cancers. He also provides targeted and anti‑angiogenic therapies for malignant tumours. He manages malignant pleural and peritoneal effusions and bone metastases with multimodal care, including immunotherapy.
He has authored more than 10 basic and clinical papers, including “Tumour Hypoxia and Its Therapeutic Strategies” and “Establishment of Tumour Model with B16 Melanoma Cell Line of C57BL/6 Mice in ICR Mice.” He received the Medical Achievement Award from the General Logistics Department of the PLA for “Research and Application of Early‑diagnosis and Prediction Model for Metastasis of Non‑small‑cell Lung Cancer.” He co‑authored “Evidence‑based Oncology Treatment” and “Handbook of Modern Evidence‑based Diagnosis and Treatment of Cancer.” He has also taken part in key projects of the National Natural Science Foundation of China.